Michael Pruskowski

219 Added | 1 Magazine | 1 Following | 55 Followers | @mpruskowski | Keep up with Michael Pruskowski on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Michael Pruskowski”

Express Scripts assembling anti-Sovaldi coalition to shut out Gilead hep C drug

<i>Express Scripts CMO Steven Miller</i><p>Express Scripts ($ESRX) and Gilead Sciences ($GILD) are playing a high-priced game of chicken. At stake is the fate …

Sign into Flipboard — Flipboard

Gilead says payers feel comfortable with the cost of Sovaldi

As soon as Gilead Sciences ($GILD) named a price for its highly anticipated hep C drug Sovaldi, activists pounced--and payers showed some nervousness …

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” …

Biotechnology

Forbes: Revolutionary Hepatitis C Drug Too Expensive? polyDNA Recommends Affordable Gene-Eden-VIR, an HCV Remedy

polyDNA recommends that doctors prescribe a safe, natural HCV remedy to their patients, which most patients can afford.<p>polyDNA has learned that …

UPDATED: Merck's 'breakthrough' hep C combo plays catch-up with promising PhII results

Merck may be playing catch-up in the race to develop the first all-oral combo treatment for hepatitis C, but it made a good case over the weekend …

Gilead Sciences, Inc. (NASDAQ:GILD) - Gilead Announces Positive Phase 3 HCV Treatment Results in Patients Co-Infected With HIV

Gilead Sciences (NASDAQ: GILD) today announced results from a Phase<br>3 study, PHOTON-1, evaluating the investigational once-daily nucleotide<br>analogue …

Eating Right - Guidelines For Hepatitis Patients

<b>Eating Right - Guidelines For Hepatitis Patients</b><p>Hope your weekend is going well folks. Here in Michigan the family spent the day collecting apples, …

Top 10 Medical Innovations for 2014: Hepatitis C Drug Sofosbuvir Number 4

Cleveland Clinic News Wire <b><br>No. 4 Innovation: A Breakthrough for Hepatitis C (Video)</b> <b><br>Better treatment in less time</b><p><i>Cleveland Clinic asked more than 100</i> …

organize, read and share what matters to you.

Feedly connects you to the information and knowledge you care about. We help you get more out of you work, education, hobbies and interests. The …

Hobbies

Know More Hepatitis

People born from 1945-1965 are 5x more likely to have Hepatitis C.<p><b>While anyone can get Hepatitis C, people born during these years are five times</b> …

NYC launches initiative to control hepatitis C prevalence in the city

The New York City Department of Health and Mental Hygiene on Monday announced the launch of an initiative to combat Hepatitis C infection, a disease …

Public Health

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients

SAN FRANCISCO – Patients with chronic hepatitis C treated with an interferon-free regimen consisting of sofosbuvir and ribavirin experienced changes …

San Francisco

J&J snaps up an NS5A inhibitor from GlaxoSmithKline for hep C cocktail

J&J is going to be late to the blockbuster, interferon-free hepatitis C party, but it appears determined to wrangle an invitation.<p>Rounding the bend …

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

<b></b><b>Journal of Viral Hepatitis</b><p>Volume 20, Issue 11, pages 745–760, November 2013<p><b>The new paradigm of hepatitis C therapy: integration of oral therapies</b> …

Close to 146,500 New Yorkers infected with hepatitis C; roughly 50 percent do not know it

<b>Health Department Announces Plan to Combat Hepatitis C</b><p>Approximately 146,500 New Yorkers are infected with hepatitis C; roughly 50 percent do not know …

Hepatitis C Interferon-free Combo - J&J Acquires Rights to NS5A inhibitor from GlaxoSmithKline

<b>J&J buys GSK Hep C compound, BI completes trial enrollment</b><p>Deborah Weinstein<br>October 08, 2013<p>GlaxoSmithKline sold its investigational hepatitis C NS5a …

Journal of Lancaster General Health - Hepatitis C - An Infection to the Past

<b>Summer 2008 - Vol.3, No.2</b><p><b><br>HEPATITIS C—DESTINED TO BECOME AN<br>INFECTION OF THE PAST?</b><p><b>Alexandra L. Gibas, M.D.</b><p>Regional Gastroenterology Associates of …

Biotechnology

Experience Project is taking a break. We thank our tens of millions of members for being a part of the largest community of shared experiences ever …

Empathy

All-Oral Therapy With Sofosbuvir and GS-0938 for 14 Days in Treatment-Naive Geno 1 Hepatitis C (NUCLEAR)

Journal of Viral Hepatitis<p><b>All-Oral Therapy With Nucleotide Inhibitors Sofosbuvir and GS-0938 for 14 Days in Treatment-Naive Genotype 1 Hepatitis C</b> …

Emerging concepts in immunity to hepatitis C virus infection.

2013 Oct;123(10):4121-30. doi: 10.1172/JCI67714. Epub 2013 Oct 1.<p>Abstract<p>Since the discovery of hepatitis C virus (HCV) by molecular cloning almost a …

Hepatitis

Bristol-Myers Squibb to Present Range of New Hepatitis C Data at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Top 15 Drug Launch Superstars

A year ago, <i>FiercePharma</i> published a list of drugs that missed when stepping on the up escalator. A heel got caught, or a sleeve. Bystanders hit the …

AASLD an IDSA to develop updated recommendations for the management of hepatitis C

<b>Leading Liver and ID Experts to Develop Hepatitis C Practice Recommendations</b><p>Recognizing the rapid development of hepatitis C medications coupled with …